Recruiting A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) NCT07401875 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, HC-7366, +12 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
